Ehab Meselhy
Anesthesiology · Dallas, TXNPI 1730573643
Payments from drug & device makers
Across 30 payments — averaging $623.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$10K
- Medtronic$8K
- Abbott$129
- GRT US Holding, Inc.$124
- Scilex Pharmaceuticals Inc.$71
- Stimwave Technologies Incorporated$68
- plus $290 from 8 others
What the payments were for
- Grants$17,50094%
- Food & beverage$1,2096%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 4 | $10,265 |
| Medtronic(2 entities) | 6 | $7,762 |
| Abbott | 1 | $129 |
| GRT US Holding, Inc. | 1 | $124 |
| Scilex Pharmaceuticals Inc. | 3 | $71 |
| Stimwave Technologies Incorporated | 1 | $68 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $64 |
| Pfizer | 3 | $60 |
| Teva Pharmaceuticals USA, Inc. | 2 | $52 |
| Collegium Pharmaceutical, Inc. | 2 | $37 |
| Nevro Corp. | 1 | $25 |
| Azurity Pharmaceuticals, Inc. | 1 | $20 |
| AbbVie | 1 | $17 |
| Averitas Pharma Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPECTRA WAVEWRITER$10,124
- SYNCHROMED$7,500
- PROCLAIM$129
- ADAPTIVESTIM$125
- Qutenza$124
- WAVEWRITER ALPHA$121
How this compares
$18,709 in reported general payments places this provider in the 95th percentile of 3,899 anesthesiology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 285 | $7,500 |
| Lidocaine | 69 | $4,939 |
| Celecoxib | 75 | $3,163 |
| Pregabalin | 46 | $2,508 |
| Gabapentin | 142 | $1,451 |
| Cyclobenzaprine Hcl | 100 | $1,073 |
| Buprenorphine Hcl | 29 | $966 |
| Methocarbamol | 51 | $721 |
| Diclofenac Sodium | 18 | $587 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 26 | $537 |
| Tizanidine Hcl | 40 | $406 |
| Baclofen | 34 | $360 |
| Tramadol Hcl | 46 | $250 |
| Duloxetine Hcl | 18 | $213 |
| Meloxicam | 28 | $47 |
Paid to pharmacies, not to this prescriber.
Other anesthesiology in Dallas
- James MuellerDallas$636K
- Peter SzmukDallas$631K
- Tiffany MoonDallas$606K
- Joseph HendrixDallas$476K
- Deryk WalshDallas$352K
- Umar KhanDallas$319K
- Gijo AlexDallas$279K
- Girish JoshiDallas$239K
- Peiman LahsaeiDallas$226K
- Kunal KaramchandaniDallas$131K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.